The trail, conducted at St Michael Hospital in Toronto, Canada, explored the safety and efficacy of twice-daily oral doses of Optina, to reduce macular oedema as determined by OCT (optical coherence tomography).
Thus treatment with Anti-VEGF could help break this vicious cycle and help in the resolution of macular oedema. Thus treatment options for managing macular oedema with BRVO include both macular grid laser photo coagulation and intravitreal injections4-8.
Despite the PRP benefits, the therapy procedure has some harmful side effects and complications, among them the most significant is the creation and exacerbation of macular oedema.  Macular thickness may increase after PRP with either transient or sustained decrease of vision.